Cash-strapped TorreyPines Divests its Alzheimer’s Disease Developments

By Taskin Ahmed

Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)

Published: 18 Nov-2008

DOI: 10.3833/pdr.v2008.i102.107     ISSN: 1756-7874

Section: Licensing



In order to raise cash to progress its clinical developments, TorreyPines Therapeutics is disposing its Alzheimer’s developments through two recently signed deals...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details